Opiolds increase the excitability of CAl pyramidal neurons in the hippocampus through the inhibition of y-aminobutyric acid re-lease from intemeurons. This can be observed extracellularly as an increase in population spike amplitude. The sulfated form of the neuropeptide cholecystokinin (CCK-8S) has been shown in a variety of in vivo models to inhibit the response to oploids. We have utilized the well-characterized hippocampal response to opioids to examine the potential interactions between morphine and the neuropeptide cholecystokinin (CCK) in vitro. Morphine (1-500 zM; ECso 22.1 M, 95 % confidence interval = 6.5-75.9 zM) alone caused concentration-dependent increases in CAl population spike amplitudes that were reversible upon washout or...
The action of enkephalin-analogues (D-ala2-D-leu5-enkephalin and D-ala2-D-met-enkephalin) and morphi...
Accepted for publication July 10,1989 Extracellular recording of population spike amplitudes in the ...
The effects of cholecystokinin octapeptide sulphated (CCK) and the potent CCK antagonist MK-329 (L-3...
The peptide cholecystokinin (CCK) antagonizes opioid-induced analgesia. Conversely, antagonists of C...
Cholecystokinin octapeptide (CCK-8), a gut-brain peptide, regulates a variety of physiological behav...
Cholecystokinin octapeptide (CCK-8), a gut-brain peptide, regulates a variety of physiological behav...
Sustained administration of morphine in humans and in animals induces a state of abnormal pain (i.e....
Cholecystokinin (CCK) is an endogenous anti-opioid peptide in the central nervous system. The presen...
To test the hypothesis that excitatory peptides release endogenous opioids from the myenteric plexus...
The potent and selective non-peptide cholecystokinin (CCK) antagonist L-364,718 (0.5-2.0 mg/kg s.c.)...
We examined the effect of acute and chronic opioid treatment on synaptic transmission and -opioid re...
Abstract Background Substances of abuse, such as opiates, have a variety of immunomodulatory propert...
Cholecystokinin (CCK) and opioid peptides have a similar distribution in the nervous system and CCK ...
States of abnormal pain induced by injuries to peripheral nerves share common features with opioid a...
This study investigated a role of cholecystokinin (CCK) in the anxiolytic-like action of morphine, a...
The action of enkephalin-analogues (D-ala2-D-leu5-enkephalin and D-ala2-D-met-enkephalin) and morphi...
Accepted for publication July 10,1989 Extracellular recording of population spike amplitudes in the ...
The effects of cholecystokinin octapeptide sulphated (CCK) and the potent CCK antagonist MK-329 (L-3...
The peptide cholecystokinin (CCK) antagonizes opioid-induced analgesia. Conversely, antagonists of C...
Cholecystokinin octapeptide (CCK-8), a gut-brain peptide, regulates a variety of physiological behav...
Cholecystokinin octapeptide (CCK-8), a gut-brain peptide, regulates a variety of physiological behav...
Sustained administration of morphine in humans and in animals induces a state of abnormal pain (i.e....
Cholecystokinin (CCK) is an endogenous anti-opioid peptide in the central nervous system. The presen...
To test the hypothesis that excitatory peptides release endogenous opioids from the myenteric plexus...
The potent and selective non-peptide cholecystokinin (CCK) antagonist L-364,718 (0.5-2.0 mg/kg s.c.)...
We examined the effect of acute and chronic opioid treatment on synaptic transmission and -opioid re...
Abstract Background Substances of abuse, such as opiates, have a variety of immunomodulatory propert...
Cholecystokinin (CCK) and opioid peptides have a similar distribution in the nervous system and CCK ...
States of abnormal pain induced by injuries to peripheral nerves share common features with opioid a...
This study investigated a role of cholecystokinin (CCK) in the anxiolytic-like action of morphine, a...
The action of enkephalin-analogues (D-ala2-D-leu5-enkephalin and D-ala2-D-met-enkephalin) and morphi...
Accepted for publication July 10,1989 Extracellular recording of population spike amplitudes in the ...
The effects of cholecystokinin octapeptide sulphated (CCK) and the potent CCK antagonist MK-329 (L-3...